Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 1FED 1

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 16Psoriasis 7Leukemia 5Lymphoma, Follicular 4Spondylitis, Ankylosing 3Myelodysplastic Syndromes 3Inflammation 3Asthma 3Arthritis, Juvenile 3Vasculitis 2Uveitis 2Respiratory Distress Syndrome 2Recurrence 2Prostatic Neoplasms 2Pneumonia 2Neuroblastoma 2Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Wilms Tumor 1Temporomandibular Joint Disorders 1Stomatitis 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Methylprednisolone 4Etanercept 2Bronchoscopy 2Bronchoalveolar Lavage 2Blood Specimen Collection 2ziprasidone 1tocilizumab 1pirfenidone 1ceftolozane, tazobactam drug combination 1Zolpidem 1XAV-19 1X-Rays 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1Sodium Bicarbonate 1Sevelamer 1Saline Solution 1Rocuronium 1Ribavirin 1Prednisone 1Piperacillin, Tazobactam Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pneumonia × Etanercept × Clear all
NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
37 enrolled 20 charts

Pneumonia

NCT00029328 2015-03-25

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

FDA Office of Orphan Products Development

Phase 1/2 Completed
15 enrolled

Bronchiolitis Obliterans, Pneumonia, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡